全文获取类型
收费全文 | 24662篇 |
免费 | 1669篇 |
国内免费 | 73篇 |
专业分类
耳鼻咽喉 | 372篇 |
儿科学 | 553篇 |
妇产科学 | 403篇 |
基础医学 | 3337篇 |
口腔科学 | 647篇 |
临床医学 | 2319篇 |
内科学 | 5547篇 |
皮肤病学 | 597篇 |
神经病学 | 1958篇 |
特种医学 | 1156篇 |
外国民族医学 | 2篇 |
外科学 | 3481篇 |
综合类 | 365篇 |
一般理论 | 19篇 |
预防医学 | 1665篇 |
眼科学 | 729篇 |
药学 | 1691篇 |
中国医学 | 50篇 |
肿瘤学 | 1513篇 |
出版年
2022年 | 181篇 |
2021年 | 347篇 |
2020年 | 166篇 |
2019年 | 321篇 |
2018年 | 376篇 |
2017年 | 317篇 |
2016年 | 429篇 |
2015年 | 467篇 |
2014年 | 648篇 |
2013年 | 1005篇 |
2012年 | 1314篇 |
2011年 | 1353篇 |
2010年 | 776篇 |
2009年 | 757篇 |
2008年 | 1304篇 |
2007年 | 1448篇 |
2006年 | 1464篇 |
2005年 | 1366篇 |
2004年 | 1388篇 |
2003年 | 1274篇 |
2002年 | 1337篇 |
2001年 | 480篇 |
2000年 | 404篇 |
1999年 | 496篇 |
1998年 | 346篇 |
1997年 | 317篇 |
1996年 | 234篇 |
1995年 | 261篇 |
1994年 | 189篇 |
1993年 | 195篇 |
1992年 | 241篇 |
1991年 | 242篇 |
1990年 | 233篇 |
1989年 | 225篇 |
1988年 | 195篇 |
1987年 | 194篇 |
1986年 | 176篇 |
1985年 | 209篇 |
1984年 | 241篇 |
1983年 | 231篇 |
1982年 | 268篇 |
1981年 | 262篇 |
1980年 | 197篇 |
1979年 | 166篇 |
1978年 | 142篇 |
1977年 | 185篇 |
1976年 | 168篇 |
1975年 | 163篇 |
1974年 | 143篇 |
1973年 | 148篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
Daniel Buser Britt Hoffmann Jeanpierre Bernard Adrian Lussi Daniel Mettler Robert K. Schenk 《Clinical oral implants research》1998,9(3):137-150
In recent years, bone grafts and bone substitutes have been increasingly utilized underneath barrier membranes to optimize the treatment outcome of bone reconstructive therapy for defects in the alveolar process. In the present study, 4 different filling materials were evaluated in bone defects of similar dimensions in the mandible of miniature pigs. Blood clots and autografts were used as controls. The defects were covered with barrier membranes and allowed to heal for 4, 12 or 24 weeks. Histologic examination demonstrated that bone repair progressed through a programmed sequence of maturation steps closely resembling the pattern of bone development and growth regardless of whether bone grafts or substitutes were present or not. Histomorphometric analysis showed that autologous bone grafts (autografts) had the best osteoconductive properties during the initial healing period, with 39% of newly formed bone inside the membrane-covered defects at 4 weeks of healing. In addition, 87% of the graft surfaces were already covered by bone at this time. Both values were significantly higher for autografts than for the 4 alternative bone fillers (P < or = 0.05). At 12 weeks, these differences were no longer apparent, with all 5 filling materials showing similar values. Among the tested bone substitutes, tricalcium phosphate (TCP) showed a significantly higher percentage of bone fill at 24 weeks of healing. It can be concluded that sites filled with autografts clearly demonstrated the best results underneath barrier membranes in the early phase of healing. As far as degradation and substitution are concerned, TCP showed the most promising results. This filler, however, needs to be tested further in a more demanding animal model. Less favorable results were obtained for coral-derived hydroxyapatite granules and for demineralized freeze-dried bone allografts. 相似文献
82.
Gregory T. Bales M.D. Susan K. Fellner M.D. Gerald W. Chodak M.D. Daniel B. Rukstalis M.D. 《Urology》1994,43(6)
Hypertension arising from retained native kidneys complicates the management of recipients of renal transplants. Reluctance to administer angiontensin-converting enzyme inhibitor (ACEI) drugs to patients taking cyclosporine has reopened the question of performing native nephrectomies for poorly controlled, renin-dependent hypertension. We report the first published cases of simultaneous bilateral laparoscopic nephrectomies in 2 patients: 1 in preparation for living-related donor transplantation and the other ten months following cadaver transplantation in a patient whose end-stage renal disease was from malignant nephrosclerosis. Both had very severe hypertension resistant to multiple drugs and both became normotensive with little or no antihypertensive medication following nephrectomies. A bilateral nephrectomy is currently feasible using a laparoscopic approach. 相似文献
83.
Deborah W. Knapp Ralph C. Richardson Gerald D. Bottoms Robert Teclaw Thomas C. K. Chan 《Cancer chemotherapy and pharmacology》1992,29(3):214-218
Summary Piroxicam, a nonsteroidal antiinflammatory drug, was given to 62 dogs bearing naturally occurring tumors in a phase I clinical trial. Dose escalation was performed, with oral doses ranging from 0.5 mg/kg every 48 h (q48h) to 1.5 mg/kg q48h being tested. Dose-limiting gastromestinal irritation/ulceration occurred in all four animals that received 1.5 mg/kg q48h. The maximum tolerated dose was 1 mg/kg q48h. Subclinical renal papillary necrosis occurred in two dogs (initial dosages, 1 and 1.5 mg/kg q48h, respectively). Following dose escalation, an additional group of dogs was treated with 0.3 mg/kg piroxicam q24h per os, the accepted canine dosage prior to this trial. Inclusion of this treatment group enabled evaluation of the toxicity of and tumor response to a daily dosage regimen. No complete remissions occurred in this trial. Partial remission was documented in three of ten dogs exhibiting transitional-cell carcinoma, in three of five animals bearing squamous-cell carcinoma, in one of three dogs displaying mammary adenocarcinoma, and in the one dog that exhibited a transmissible venereal tumor. The results of this study support the additional evaluation of piroxicam in a phase II clinical trial in dogs bearing naturally occurring tumors.This investigation was supported by Pfizer Inc. 相似文献
84.
Supercritical fluid extraction in the determination of tobacco-specific N-nitrosamines in smokeless tobacco. 总被引:6,自引:0,他引:6
B Prokopczyk D Hoffmann J E Cox M V Djordjevic K D Brunnemann 《Chemical research in toxicology》1992,5(3):336-340
A new approach to the analysis of the carcinogenic, tobacco-specific N-nitrosamines (TSNA) in moist snuff tobacco is based on the extraction of tobacco with methanol-modified supercritical carbon dioxide. Extracted TSNA are trapped across a glass cartridge filled with Tenax GR, from which they are subsequently released by thermal desorption and analyzed by capillary gas chromatography with a thermal energy analyzer. The analytical recoveries for the major TSNA range from 83 to 98%; the detection limits are below 2 ng/g. The methodology is fast, reproducible, highly selective, and sensitive. The supercritical fluid extraction (SFE) releases up to 7 times more of the highly carcinogenic 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) from tobacco than has been determined after conventional solvent extraction. Studies have confirmed that this is not an artifact. In contrast, the cyclic N-nitrosamines, N'-nitrosonornicotine, N'-nitrosoanabasine, and N'-nitrosoanatabine, showed no significant quantitative differences whether determined by the SFE method or the conventional solvent extraction method. 相似文献
85.
86.
Gerald Gabriel 《医疗保健器具》2007,(10):65-65,67
事物的本质人类的智力是虚幻的,是难以受到约束的。甚至难以给它一个定义。智力可以用能力来解释吗?和记忆力有关吗?它和语言有关吗?还是数学?还是和上面的都有关系呢?只要你说你只是不能衡量智力,许多人会离去。为了使一个人 相似文献
87.
P L Tisdale B D Collier H M Kauffman M B Adams A T Isitman R S Hellman R G Hoffmann S A Rao T Joestgen L Krohn 《Journal of nuclear medicine》1986,27(8):1266-1272
A prospective evaluation of 111In-labeled platelet scintigraphy (IPS) for the early diagnosis of acute postoperative renal transplant rejection (TR) was undertaken. The results of IPS were compared with in vitro biochemical tests, the clinical finding of graft tenderness, and combined [99mTc]DTPA and [131I]orthoiodohippurate scintigraphy. With a sensitivity of 0.93 and a specificity of 0.95, IPS provided otherwise unavailable diagnostic information. Furthermore, postoperative IPS was a good predictor of long-term allograft survival. 相似文献
88.
Gerald V. Goresky 《Journal canadien d'anesthésie》1994,41(7):655-655
89.
Simone Maschauer Olaf Prante Markus Hoffmann J Thiess Deichen Torsten Kuwert 《Journal of nuclear medicine》2004,45(3):455-460
The contribution of (18)F-FDG uptake by endothelial cells to uptake values measured by PET in various tissues is as yet unclear. We therefore sought to characterize (18)F-FDG uptake in an in vitro model of human endothelial cells. METHODS: Commercially obtained human umbilical vein endothelial cells (HUVECs) were seeded in 6-multiwell plates 48-96 h before incubation with 1-2 MBq (18)F-FDG per well. Radioactivity measurements were performed after washing and mechanical dissolvation of the cellular monolayers. Cellular (18)F-FDG uptake was referred to protein concentration. This experimental protocol was subsequently varied to study the effect of different parameters of interest. Furthermore, radio-thin-layer chromatography was used to identify intracellular (18)F-FDG metabolites. (18)F-FDG uptake in HUVECs was compared with that by a human monocyte-macrophage (HMM) preparation and by glioblastoma cells (GLIOs) under identical experimental conditions. RESULTS: (18)F-FDG accumulated in HUVECs in a time-dependent manner and was trapped mainly as (18)F-FDG-6-phosphate and (18)F-FDG-1,6-diphosphate. Unlabeled glucose and cytochalasin B competitively inhibited (18)F-FDG uptake, whereas phlorizin had no significant effect. Glucose deprivation significantly enhanced (18)F-FDG uptake by a factor of 2.7, whereas sodium depletion had no significant influence. HUVECs treated with vascular endothelial growth factor (VEGF) showed a significant 82% increase in (18)F-FDG accumulation after a 2-h exposure to 50 ng/mL VEGF. (18)F-FDG uptake in HUVECs was significantly higher than that in HMMs and in the range of the uptake values measured in GLIOs. CONCLUSION: (18)F-FDG accumulates in HUVECs by mechanisms analogous to those in neoplastic cells or neurons. VEGF significantly stimulates endothelial (18)F-FDG uptake. The observed differences in (18)F-FDG uptake between HUVECs, HMMs, and GLIOs are difficult to extrapolate to in vivo conditions but stimulate further studies on the contribution of endothelial (18)F-FDG uptake to the overall uptake of that tracer in neoplastic or vascular lesions. 相似文献
90.
The duration of response to treatment with alefacept has been assessed in patients with moderate to severe chronic plaque psoriasis who responded to alefacept therapy in phase 2 and phase 3 clinical studies. In a phase 2 trial, duration of response was based on time to retreatment with alefacept. In two phase 3 studies, the more objective measure of maintenance of a ≥50% reduction from baseline Psoriasis Area and Severity Index (PASI 50) was used. Two patient subsets were analyzed: (1) those who achieved a PASI 75 at any time during the trials and (2) those who achieved a Physician Global Assessment of “clear” or “almost clear” at any time during the trials. Regardless of the criterion used or the route of alefacept administration (intravenous or intramuscular), the median duration of response to alefacept therapy ranged from 7 to 10 months across the three studies. Alefacept is a remittive therapy for psoriasis. 相似文献